Why HQAir?
Removes 99.99% of novel coronavirus (COVID-19) from air and surfaces within one hour
The OHAir Hydroxyl technology has been extensively tested against DNA / RNA based viruses (the approach used in FDA approved testing) – demonstrating that OHAir is effective against a full range of viruses, no matter their protective lipid sheaths. These viruses are a surrogate for COVID-19 – making OHAir a fast and effective treatment solution to this virus.
OHAir is the only technology available that can actively reduce the viral contamination in occupied spaces, reducing the risk of cross contamination. The difference being that the air does not need to pass through the unit – it projects safe treatment throughout the entire space.
OHAir technology has also been through FDA’s rigorous safety and efficacy testing where it provided consistant results of > 99.99% reduction in virus, bacteria and mould within 2-3 hours.

Pictured: FDA testing of MS2 virus, a surrogate for COVID-19. The MDU testing showed a level of efficacy of 99% (2 log reduction) in contamination within 15 to 30 minutes – an exceptionally fast treatment rate. Overall the system achieved a 4 -5 log reduction (99.99% and 99.999%) within two hours – far exceeding FDA standards.